Most people lose about 10 to 20 percent of their body weight on semaglutide over a full program, and where you land depends on your starting weight, your dose, and how consistently you stay with it. In the STEP 1 trial published in the New England Journal of Medicine in 2021, adults on weekly semaglutide lost roughly 15 percent of their body weight on average over 68 weeks. That range holds up in practice, but it describes what is typical, not a number anyone can promise you.
The reason semaglutide works comes down to appetite. It mimics GLP-1, a hormone your gut releases after eating that tells your brain you are full. With that signal turned up, you eat less without white-knuckling through constant hunger. The weight comes off gradually because the dose builds slowly over weeks, giving your body time to adjust and easing side effects along the way.
If you want a higher typical ceiling, tirzepatide is the dual-action option. It targets both GLP-1 and a second hormone called GIP, and in the SURMOUNT-1 trial the highest dose produced average weight loss above 20 percent. Optima offers both semaglutide and tirzepatide, and your provider helps you choose based on your goals and how your body responds. Your actual result is individual, so treat these figures as expected ranges rather than a guaranteed outcome.
Weight loss on semaglutide builds gradually because the dose climbs gradually. The medication is a GLP-1 (glucagon-like peptide-1) receptor agonist, which quiets appetite and slows how fast your stomach empties. Your provider raises the dose in steps so your body adjusts and side effects stay manageable. The checkpoints below draw on the STEP trials, the clinical studies that established what semaglutide does over time.
In the first month, expect modest but real change, often around 2 to 5 percent of body weight. You start at a low dose, typically 0.25mg (10 units on your chart), which is designed to introduce the medication rather than drive fast loss. Most of what you notice early is reduced hunger and smaller portions, and the scale follows behind that.
By three months, results become clearer as your dose steps up toward 0.5mg and beyond. In the STEP trials, participants saw steady, accelerating loss through this window as they reached higher, more active doses. Many people land somewhere near 5 to 10 percent of starting weight by this point, though your pace depends on starting weight, dose tolerance, and how consistently you eat and move.
Optima's semaglutide program runs 10 weeks, which puts you squarely inside that building phase. Over those weeks your provider guides you through the titration steps rather than parking you at the starting dose. That structure matters, because the trial data shows results keep improving as the dose rises. A flat starting dose leaves progress on the table.
At six months, the numbers in the STEP trials climbed meaningfully, with average loss approaching the mid-teens as percent of body weight for many participants on the full therapeutic dose. By now you are typically at a maintenance dose, and the appetite control feels routine rather than novel. Loss often slows compared with the early months, which is normal as your body settles.
At twelve months, the STEP research reported average total body-weight loss in the range of roughly 15 percent for many semaglutide participants, with results varying widely person to person. Tirzepatide, studied in the SURMOUNT trials, acts on two hunger pathways (GLP-1 and GIP, another gut hormone), and its trials showed a higher typical ceiling over the same span. That dual action is why some people choose tirzepatide when semaglutide plateaus below their goal.
These figures describe averages from clinical studies, not a promise for any one person. Where you land depends on your starting weight, your dose, and how well the plan fits your daily life. The pattern to remember is simple. Results build as the dose builds, which is exactly why provider-guided titration does the heavy lifting.
The 10-20% range describes what most patients see, not a number the medication delivers on its own. Semaglutide quiets your appetite and helps you feel full sooner, but where you land in that range depends heavily on what you do alongside it. Two patients on the same dose can end up in different places based on how they eat, move, and recover.
A Mediterranean-style eating pattern gives you the strongest foundation. Build meals around vegetables, whole grains, olive oil, fish, and legumes, and lean slightly higher on protein than you might expect. Protein preserves lean muscle while you lose fat, and it keeps you satisfied when the medication has already reduced your appetite.
Movement matters just as much. The American Heart Association recommends 150 minutes of moderate aerobic activity each week, or 75 minutes of vigorous activity, plus muscle-strengthening work on two or more days. That combination protects your muscle and supports the fat loss the medication drives.
Other factors shift your results too. Your starting weight, how well you tolerate each dose increase, how consistently you take the medication, and how well you sleep and manage stress all play a part. None of these guarantee a specific outcome, and honest care means saying so.
Your Optima provider works with you through all of it, adjusting your plan as your body responds. The medication does real work. Pairing it with steady habits is how you reach the upper end of what's typical.
Semaglutide works by copying a hormone called GLP-1 that tells your brain you're full, but your body adjusts to a fixed dose over time. If you stay at your starting dose forever, appetite signals weaken and weight loss slows to a plateau. A gradual increase keeps the appetite effect strong enough to matter, which is why results build across months instead of stalling after the first few weeks. Providers who leave patients parked at 0.25mg often see that stall, and patients blame the medication when the real problem is a dose that never moved.
At Optima, your provider steps you up on a schedule your body can tolerate, and you get a customized PDF dosing chart that translates milligrams into the units you draw. On that chart, 0.25mg equals 10 units, 0.5mg equals 20 units, and 0.75mg equals 30 units. The chart removes the guesswork so you know exactly what to draw each week, and your provider adjusts the plan based on how you respond.
This is provider-guided titration, not a self-directed experiment. The same licensed nurse practitioner who starts you also decides when to raise the dose, and slows or holds it if side effects flare. That oversight matters because a dose increase that comes too fast causes nausea, and one that never comes leaves results on the table. Moving through the steps at the right pace for your body is what keeps the appetite effect working long enough to reach the 10-20% range that clinical trials describe. The increase is not a bonus feature. It's the part of the plan that keeps the scale moving.
Semaglutide works differently from the weight-loss drugs that came before it, and that difference explains why the results are larger. Phentermine acts as a stimulant that suppresses hunger for short stretches, and it carries dosing limits and stimulant side effects that make long-term use impractical for many people. Orlistat blocks your gut from absorbing some of the fat you eat, which produces modest loss and often uncomfortable digestive effects. Both work at the margins of how much you eat or absorb.
Semaglutide is a GLP-1 medication, meaning it mimics a hormone your body already makes to regulate appetite and fullness. Instead of forcing hunger down for a few hours, it changes how satisfied you feel after eating, so you naturally want less food across the day. That mechanism is the reason the outcome gap is so wide. Older medications generally produced single-digit percentages of body-weight loss, while GLP-1s in the STEP trials reached the roughly 10 to 20 percent range over a full program.
The dosing tells the same story in plain numbers. Semaglutide titrates in small, precise steps, starting around 0.25mg (10 units on your dosing chart) and building gradually to 0.5mg (20 units) and beyond. Phentermine is typically prescribed in fixed daily milligram tablets with little room to climb, and orlistat is a set capsule taken with meals. The ability to raise a GLP-1 dose over time is what lets results keep building.
None of this makes the older drugs useless. GLP-1 medications simply represent the next generation, built on a better understanding of how appetite works.
Semaglutide runs $249 for a 10-week program, and tirzepatide runs $499 for 10 weeks. You pay for the medication once, and your provider guides the dosing so the vial lasts through the program. That structure is not a subscription, and no monthly charge shows up on your card.
Every price is all-inclusive. The medication, injection supplies, your consultation, and discreet home shipping are covered in the number you see, with no hidden fees, contracts, or memberships stacked on later. You know your full cost before you start.
Optima is owned and run by licensed nurse practitioners in Tyler, Texas, so you can visit the clinic in person or work with the same providers through statewide telehealth. The price covers that care either way. You get the medication, the supplies, and a real clinician overseeing your dosing from your first consult through follow-up.
How fast do results start on semaglutide? Most patients notice reduced appetite within the first week or two, though visible weight loss usually shows up over the first month. In the STEP trials, semaglutide patients lost weight steadily across the full program rather than all at once. Early changes tend to feel like smaller portions and less snacking before the scale moves much.
Are weight-loss results guaranteed? No. Optima frames the typical 10-20% body-weight range as an expected outcome, not a promise, because results depend on your starting weight, dose tolerance, adherence, and daily habits. Some patients land above that range and some below it. A licensed nurse practitioner reviews your progress and adjusts your plan along the way.
What's the expected difference between semaglutide and tirzepatide? Semaglutide works on one hormone pathway (GLP-1), while tirzepatide works on two (GLP-1 and GIP), which is why tirzepatide tends to produce a higher typical weight-loss ceiling in the SURMOUNT trials than semaglutide did in the STEP trials. Both are effective, and the right choice depends on your goals, response, and budget. Optima's semaglutide program runs $249 for 10 weeks and tirzepatide runs $499 for 10 weeks.
What happens after the 10-week program? Your provider reviews your progress at the end of the 10 weeks and discusses whether to continue, adjust your dose, or shift your plan based on where you are. Many patients keep going to reach their goal, since weight loss on these medications builds over months rather than finishing in ten weeks. There's no automatic subscription. You decide with your provider what comes next.
Do I have to come in person? No. Optima serves patients across Texas through telehealth, with discreet home delivery of your medication and supplies. If you're in or near Tyler and prefer face-to-face care, an in-person option is available. The same nurse practitioners handle your consult and follow-up either way.
Your typical range depends on your starting weight, your dose, and how your body responds, so the honest next step is a conversation with a provider who can map it out with you. Book a consultation with Optima's licensed nurse practitioners, who own and run the practice right here in Tyler, Texas, with statewide telehealth and discreet home delivery.
Call (903) 459-6864 to get started. Less weight. More life.